fifteen patients with acute nonlymphocytic leukemia have been randomized for treatment with daunorubicin ( 1.0 -- 1.5 mg/kg ) either as the free drug ( for 45 min or 4 h ) or as the drug bound to a dna carrier ( for 5 -- 6 h ) .
C0023467
acute nonlymphocytic leukemia
C0011015
daunorubicin